As of 2026-01-20, the EV/EBITDA ratio of Fortress Biotech Inc (FBIO) is -1.24. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. FBIO's latest enterprise value is 82.65 mil USD. FBIO's TTM EBITDA according to its financial statements is -66.56 mil USD. Dividing these 2 quantities gives us the above FBIO EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 12.7x - 14.4x | 13.6x |
| Forward P/E multiples | 22.0x - 43.4x | 32.7x |
| Fair Price | (46.12) - (29.82) | (48.53) |
| Upside | -1339.7% - -901.7% | -1404.6% |
| Date | EV/EBITDA |
| 2026-01-12 | -1.47 |
| 2026-01-09 | -1.51 |
| 2026-01-08 | -1.55 |
| 2026-01-07 | -1.50 |
| 2026-01-06 | -1.47 |
| 2026-01-05 | -1.50 |
| 2026-01-02 | -1.39 |
| 2025-12-31 | -1.21 |
| 2025-12-30 | -1.18 |
| 2025-12-29 | -1.18 |
| 2025-12-26 | -1.25 |
| 2025-12-24 | -1.22 |
| 2025-12-23 | -1.19 |
| 2025-12-22 | -1.20 |
| 2025-12-19 | -1.16 |
| 2025-12-18 | -1.06 |
| 2025-12-17 | -1.11 |
| 2025-12-16 | -1.14 |
| 2025-12-15 | -1.06 |
| 2025-12-12 | -0.87 |
| 2025-12-11 | -0.88 |
| 2025-12-10 | -0.88 |
| 2025-12-09 | -0.83 |
| 2025-12-08 | -0.85 |
| 2025-12-05 | -0.83 |
| 2025-12-04 | -0.79 |
| 2025-12-03 | -0.76 |
| 2025-12-02 | -0.71 |
| 2025-12-01 | -0.78 |
| 2025-11-28 | -0.82 |
| 2025-11-26 | -0.79 |
| 2025-11-25 | -0.76 |
| 2025-11-24 | -0.70 |
| 2025-11-21 | -0.71 |
| 2025-11-20 | -0.69 |
| 2025-11-19 | -0.72 |
| 2025-11-18 | -0.75 |
| 2025-11-17 | -0.72 |
| 2025-11-14 | -0.73 |
| 2025-11-13 | -0.67 |
| 2025-11-12 | -0.73 |
| 2025-11-11 | -0.76 |
| 2025-11-10 | -0.71 |
| 2025-11-07 | -0.72 |
| 2025-11-06 | -0.68 |
| 2025-11-05 | -0.66 |
| 2025-11-04 | -0.66 |
| 2025-11-03 | -0.64 |
| 2025-10-31 | -0.70 |
| 2025-10-30 | -0.71 |